PubMed · 2014 · 19 citations · 2 references
Life SciencesOncologyPharmacologyApoptosisAutophagyCancer PharmacologyApoptosis In CancerApoptosis PharmacologyApoptotic SignalingAutophagy In CancerAutophagy Signaling PathwaysMitophagyAnnexin V AssaysAnnexin V ImagingApoptosis Signaling In CancerApoptotic Signaling In CancerCancer-associated AutophagyCell Cycle InhibitionMtor Complex 1 RegulationMtorc1 Signaling
We have recently shown that the novel anthelmintic drug monepantel (MPL) inhibits growth, proliferation and colony formation, arrests the cell cycle and induces cleavage of PARP-1 in ovarian cancer cell lines. Here we report on the mechanism behind the anticancer properties of MPL. The cytotoxic effect of MPL on ovarian cancer cells (OVCAR-3 and A2780) was investigated employing a panel of tests used for the detection of apoptosis and autophagy. Apoptosis and autophagy were defined by caspase activity, DNA-laddering, Annexin-V and acridine orange (AO) staining. Autophagy markers such as LC3B, SQSTM1/p62 and mammalian target of rapamycin (mTOR) pathway related proteins were assessed by western blotting and ELISA techniques. MPL did not activate caspases 3 or 8, nor did it alter the percentage of Annexin V positive stained cells. Failure to cause DNA laddering and the inability of z-VAD-fmk to block the MPL antiproliferative effects led to the ruling out of apoptosis as the mechanism behind MPL-induced cell death. On the other hand, accumulation of acidic vacuoles with distinct chromatin morphology and an increase in punctuate localization of green fluorescent protein-LC3B, and MPL-induced changes in the expression of SQSTM1/p62 were all indicative of MPL-induced autophagy. Consistent with this, we found inhibition of mTOR phosphorylation leading to suppression of the mTOR/p70S6K signalling pathway. Our findings provide the first evidence to show that MPL triggers autophagy through the deactivation of mTOR/p70S6K signalling pathway.
2
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.
Shoshana Paglin, Timothy Hollister, Thomas Delohery et al. · PubMed · 2001 · 959 citations
Medicine, Cell Biology, Oncology +17